Broad Institute
Jaguar Gene Therapy to Kick off Phase I Trial of Autism, Phelan-McDermid Syndrome Gene Therapy
The gene therapy candidate delivers a functional SHANK3 minigene as a potential treatment for a genetic form of autism and Phelan-McDermid syndrome.
Labs, Doctors Still Grapple With Patient Recontact Despite Streamlined Variant Reclassification
Premium
Although leading labs have coalesced around the value of protocols for making sure updated variant calls get to patients, strategies still vary and practical challenges remain.
Delphia Therapeutics Launches With $67M Series A Financing
The firm is developing a new class of drugs that kill cancer cells by over-activating oncogene pathways.
All of Us Data Leads to New Genetic Variants, Disease Risk Contributors
A collection of papers has provided a look at findings from the All of Us Research Program's release of 245,388 clinical-grade genome sequences.
New Lung Cancer Evolution, Treatment Response Patterns Emerge From TRACERx Study
TRACERx researchers reported on non-small cell lung cancer features linked to disease progression, recurrence, treatment response, and more in seven new papers.
Mar 3, 2021
Jul 24, 2020
May 16, 2018